We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,861

Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


Study Claims Carrageenan Causes No Adverse Effects
  • Shook Hardy & Bacon LLP
  • USA
  • August 12 2016

A study commissioned by the International Food Additives Council (IFAC) has claimed that when used as a gelling or thickening agent in foods


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Decoding patent-eligibility of diagnostic methods
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2016

Figuring out whether an invention is patent-worthy has become a bit easier, thanks to the Federal Circuit’s clarifications in Genetic Technologies


Claudia Kalb, “Culture of Corpulence,” Newsweek, March 22, 2010
  • Shook Hardy & Bacon LLP
  • USA
  • March 19 2010

This article invokes public-health campaigns of the past, including measures taken to increase seat belt use and stop drunk driving, to call for "big-think solutions" to the nation's obesity problems


Prop. 65 litigation ends in agreements to remove cocamide DEA from products
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

According to the Center for Environmental Health (CEH), which has sued some 150 personal-care product companies for failing to warn consumers about


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning


FDA steps up issuance of warning letters to cosmetic and dietary supplement companies
  • Shook Hardy & Bacon LLP
  • USA
  • April 1 2015

The Food and Drug Administration (FDA) has issued a number of Warning Letters to cosmetic and dietary supplement companies over the last several


Pomegranate juice allegedly linked to heightened neurodegeneration in Parkinson’s disease
  • Shook Hardy & Bacon LLP
  • USA
  • April 25 2014

University of Pittsburgh and Purdue University researchers have purportedly found that pomegranate juice (PJ) heightened neurodegeneration in an


Noodle class action dismissed
  • Shook Hardy & Bacon LLP
  • USA
  • August 21 2015

A California federal court recently dismissed a proposed class action over alleged trans fat in defendant's Cup Noodle products. See Guttmann v